Combined effects of adenovirus-mediated wild-type p53 transduction, temozolomide and poly (ADP-ribose) polymerase inhibitor in mismatch repair deficient and non-proliferating tumor cells
Open Access
- 1 May 2001
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Differentiation
- Vol. 8 (5), 457-469
- https://doi.org/10.1038/sj.cdd.4400832
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemiaBritish Journal of Cancer, 1999
- Life without DNA repairProceedings of the National Academy of Sciences, 1997
- p53, the Cellular Gatekeeper for Growth and DivisionCell, 1997
- Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trialsCancer Treatment Reviews, 1997
- 3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activityBritish Journal of Cancer, 1996
- P53, cell cycle control and apoptosis: Implications for cancerCancer and Metastasis Reviews, 1995
- Cell Cycle Control and CancerScience, 1994
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- The p53 tumour suppressor geneNature, 1991
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal CarcinomasScience, 1989